You are here
Generic Version of Norvasc Granted Final Approval
Lupin's Amlodipine Besylate Tablets are the AB-rated generic equivalent of Pfizer's Norvasc (product,search)(R) Tablets, a long-acting calcium channel blocker indicated for the treatment of hypertension. The brand product had annual sales of approximately $2.7 billion for the twelve months ended December 2006, based on IMS (product,search) Health sales data.
Commenting on the approval, Vinita Gupta, President and Managing Director of Lupin Pharmaceuticals, Inc. said, "We are pleased with the approval of Amlodipine Besylate tablets." Ms. Gupta added, "This approval broadens our growing portfolio of cardiovascular medications, and we look forward to offering this cost-effective alternative to patients in the U.S."
Source: Lupin Pharmaceuticals